date,title,source
Oct-17-18,2 Big Pharmas Pleased With J&J's Third-Quarter Earnings Report,Motley Fool
Oct-17-18,Pfizer outlines early retirement program ahead of layoffs,American City Business Journals
Oct-17-18,Pfizer to cut around 2 percent of jobs through early next year,Reuters
Oct-17-18,Pfizer to cut around 2 percent of jobs through early next year,Reuters
Oct-17-18,Pfizer to cut around 2 pct of jobs through early next year,Reuters
Oct-17-18,Drug giant Pfizer offers early retirement ahead of layoffs in memo to employees,CNBC
Oct-17-18,"Top Research Reports for Pfizer, Caterpillar & Charter Communications",Zacks
Oct-18-18,Australian watchdog's appeal against Pfizer ruling dismissed by court,Reuters
Oct-18-18,Court dismisses Australian watchdog's appeal against Pfizer ruling,Reuters
Oct-18-18,Will Pfizer hit $50? Is Cleveland-Cliffs a safe bet ahead...,CNBC Videos
Oct-18-18,Dow stocks Pfizer and UnitedHealth could be safety plays amid market volatility,CNBC
Oct-18-18,Pfizer Confirms to Cut Workforce by 2%,TheStreet.com
Oct-18-18,"Merck, Pfizer combo treatment meets main goals of kidney cancer trial",Reuters
Oct-18-18,Is Sangamo Therapeutics Inc. a Buy?,Motley Fool
Oct-19-18,[$$] Pain Treatment Developer Centrexion Reveals IPO Plans,The Wall Street Journal
Oct-19-18,2 Dow Safety Stock for Volatile Market: Portfolio Manager,Investopedia
Oct-19-18,"What $1,000 in Stocks Invested 10 Years Ago Would Be Worth Today",GoBankingRates
Oct-19-18,Today's Research Reports on Trending Tickers: Pfizer and Novartis,ACCESSWIRE
Oct-22-18,Pfizer (PFE) Stock Moves -0.29%: What You Should Know,Zacks
Oct-22-18,Strong Earnings Enough Reason to Stay Long JNJ Stock,InvestorPlace
Oct-23-18,Pfizer-Lilly non-opioid drug helps reduce osteoarthritis pain,Reuters
Oct-23-18,New pain drug from Pfizer and Eli Lilly shows promise as opioid alternative,MarketWatch
Oct-23-18,Complete Results from First Study in Ongoing Phase 3 Program for Tanezumab Demonstrated Significant Improvement in Pain and Function in Osteoarthritis Patients,Business Wire
Oct-23-18,[$$] Cooper's Take: Bain Puts PE Polish on Traditional VC-Pharma Play,The Wall Street Journal
Oct-23-18,How To Use Pivot Points In Your Trading,Benzinga
Oct-23-18,"[$$] Pfizer, Bain Create Company Focused on Nervous System Diseases",The Wall Street Journal
Oct-23-18,"[$$] Pfizer, Bain Capital Create New CNS Company",The Wall Street Journal
Oct-23-18,"Bain, Pfizer launch biotech startup to tackle brain disorders",American City Business Journals
Oct-23-18,Bain Capital teams with Pfizer to create new neuroscience-focused company,CNBC
Oct-24-18,"Pfizer Succeeds in Pain Study, Forms JV to Make CNS Drugs",Zacks
Oct-24-18,Healthcare ETFs to Buy Ahead of Q3 Earnings,Zacks
Oct-24-18,New pain drug from Pfizer and Eli Lilly shows promise as opioid alternative,MarketWatch
Oct-25-18,Pfizer Rises 3%,Investing.com
Oct-25-18,Pfizer (PFE) to Report Q3 Earnings: What's in the Cards?,Zacks
Oct-25-18,"3 Big Stock Charts for Thursday: Pfizer, Philip Morris and Dominion Energy",InvestorPlace
Oct-26-18,BioMarin (BMRN) Q3 Earnings & Revenues Surpass Estimates,Zacks
Oct-26-18,"Pharma Stock Roundup: MRK, BMY Q3 Earnings, Cancer Data Presentations at ESMO",Zacks
Oct-29-18,Day Ahead: Top 3 Things to Watch,Investing.com
Oct-29-18,Pfizer earnings: Looking toward an ambitious 2022 agenda,MarketWatch
Oct-29-18,7 Bitcoin Stocks That You Wont Lose Your Shirt Over,InvestorPlace
Oct-29-18,Pfizer's Q3 Earnings Preview,Benzinga
Oct-29-18,"Stocks Attempt Rally, IBM Buys Red Hat, & Q3 Earnings Season Stays Hot",Zacks
Oct-29-18,What's in Store for Sangamo (SGMO) This Earnings Season?,Zacks
Oct-29-18,"Novartis, Pfizer join forces on potentially lucrative fatty liver disease",Reuters
Oct-29-18,Pfizer Announces Clinical Development Agreement with Novartis to Advance the Treatment of NASH,Business Wire
Oct-30-18,"[$$] Pfizer Narrows Guidance on Tougher Pricing, Generic Competition",The Wall Street Journal
Oct-30-18,"Amgen Earnings, Revenue beat in Q3",Investing.com
Oct-30-18,Business Highlights,Associated Press
Oct-30-18,Dow Closes Sharply Higher as Late Surge Pushes Stock Gains,TheStreet.com
Oct-30-18,"Pfizer will go back to price hikes as normal come January, CEO suggests",MarketWatch
Oct-30-18,5 Things You Might Miss in Pfizer's Q3 Earnings Without Reading the Fine Print,Motley Fool
Oct-30-18,Profit for Viagra-maker Pfizer spikes in Q3,American City Business Journals
Oct-30-18,Pfizer revenue worse than expected as generic competition weighs,Reuters
Oct-30-18,Pfizer revenue worse than expected as generic competition weighs,Reuters
Oct-30-18,Pfizer revenue worse than expected as generic competition weighs,Reuters
Oct-30-18,Pharma's support of Trump's drug pricing plan is fraying heading into midterms,CNBC
Oct-30-18,US STOCKS-Wall Street moves higher as chip stocks rebound,Reuters
Oct-30-18,"Pfizer's 3Q profit, up due to tax cut, beats expectations",Associated Press
Oct-30-18,"[$$] Pfizer Narrows Guidance on Tougher Pricing, Generic Competition",The Wall Street Journal
Oct-30-18,Pfizer CEO says tying drug prices to foreign countries is...,CNBC Videos
Oct-30-18,US STOCKS-Wall Street gains as chip stocks lead bounce back,Reuters
Oct-30-18,Pfizer's Lingering Hospira Woes Are Troubling,Bloomberg
Oct-30-18,"HCA Earnings, Revenue beat in Q3",Investing.com
Oct-30-18,"Stocks - Coca-Cola, Apple Gain in Pre-market; GE, Pfizer Sink",Investing.com
Oct-30-18,"Pfizer (PFE) Beats on Q3 Earnings, Meets Sales, Narrows View",Zacks
Oct-30-18,Pfizer CEO designate does not see need for large acquisitions,Reuters
Oct-30-18,US STOCKS-U.S. stocks ride higher on trade optimism,Reuters
Oct-30-18,"Stocks - U.S. Futures Rise As GE, Coca-Cola Report Earnings",Investing.com
Oct-30-18,"Pfizer cuts revenue forecast as supply snags, dollar strength weigh",Reuters
Oct-30-18,"Pfizer Earnings beat, Revenue misses In Q3",Investing.com
Oct-30-18,Pfizer Narrows Forecast as Older Drugs Business Struggles,Bloomberg
Oct-30-18,"Stocks struggle to rebound after mixed earnings from Coca-Cola and Pfizer, downbeat housing report",MarketWatch
Oct-30-18,Top 5 Things to Know in the Market on Tuesday,Investing.com
Oct-30-18,US STOCKS-Wall St set to open higher on trade optimism,Reuters
Oct-30-18,"Pfizer cuts revenue forecast as supply snags, dollar strength weigh",Reuters
Oct-30-18,Pfizer (PFE) Q3 Earnings Beat Estimates,Zacks
Oct-30-18,"Pfizer Tops Q3 Earnings Estimate, Narrows Full-Year Guidance Range",TheStreet.com
Oct-30-18,US STOCKS-Futures higher on Trump's optimistic comments on China trade deal,Reuters
Oct-30-18,"Stocks making the biggest move premarket: KO, GE, PFE, TPR, UAA & more",CNBC
Oct-30-18,[$$] Pfizer outlook dented by strong dollar and legacy drug unit,Financial Times
Oct-30-18,Pfizer's a tan minivan these days and that's a good thing...,CNBC Videos
Oct-30-18,"Pfizer posts mixed third-quarter results, narrows full-year forecast, shares drop",CNBC
Oct-30-18,"Pfizer's stock falls after profit beats, but revenue misses",MarketWatch
Oct-30-18,PFIZER REPORTS THIRD-QUARTER 2018 RESULTS,Business Wire
Oct-30-18,Pfizer posts mixed quarter,CNBC Videos
Oct-31-18,"Baxter Earnings beat, Revenue misses In Q3",Investing.com
Oct-31-18,Edited Transcript of PFE earnings conference call or presentation 30-Oct-18 2:00pm GMT,Thomson Reuters StreetEvents
Oct-31-18,"Pfizer will go back to price hikes as normal come January, CEO suggests",MarketWatch
Oct-31-18,10 Hot Stocks to Buy Right Now,InvestorPlace
Oct-31-18,Big Pharma's Price Freezes Aren't Fooling Anybody,Bloomberg
Oct-31-18,Todays Research Reports on Stocks to Watch: Daxor and Pfizer,ACCESSWIRE
Nov-01-18,Pfizer and Coca-Cola Earnings Help Safer Income Stocks Shine,Zacks
Nov-01-18,Pfizer cut to market perform at BMO,CNBC Videos
Nov-01-18,BMO: Significant Headwinds Will Cap Pfizer Upside,Investopedia
Nov-01-18,"BMO Downgrades Pfizer After Q3 Print, Says Risk-Reward 'Fairly Balanced'",Benzinga
Nov-01-18,Edited Transcript of PFE earnings conference call or presentation 30-Oct-18 2:00pm GMT,Thomson Reuters StreetEvents
Nov-01-18,Has Pfizer (PFE) Outpaced Other Medical Stocks This Year?,Zacks
Nov-01-18,"Zoetis Inc Earnings, Revenue beat in Q3",Investing.com
Nov-01-18,3 Pharma Stocks to Make a Portfolio Feel Better,Investopedia
Nov-01-18,Pfizer weighing sale of women's health portfolio - Bloomberg,Reuters
Nov-01-18,Here's What Exact Sciences Just Said About Its Future,Motley Fool
Nov-01-18,Pfizer downgraded by BMO: 'Significant headwinds' will cap the drugmaker's stock run,CNBC
Nov-01-18,"Stocks making the biggest move premarket: DWDP, NFX, ECA, AAPL, CI & more",CNBC
Nov-01-18,"Pfizer will go back to price hikes as normal come January, CEO suggests",MarketWatch
Nov-02-18,FDA approves Pfizer's treatment for certain lung cancer patients,Reuters
Nov-05-18,"Bulls & Bears Of The Week: Amazon, Apple, Ford, GE And More",Benzinga
Nov-05-18,Biogen Stock Rebounds After Impressive Q3 Earnings,InvestorPlace
Nov-05-18,Hedge Funds Are Piling Into This Stock,Insider Monkey
Nov-06-18,Pfizer (PFE) Stock Sinks As Market Gains: What You Should Know,Zacks
Nov-06-18,Eli Lilly's Conservative Pricing Offers Protection From Political Pressure,TheStreet.com
Nov-06-18,"New Clinical Oncology Collaboration Between Nektar and Pfizer to Evaluate Combination of NKTR-214, a CD122-Biased Agonist, with Avelumab and Talazoparib or Enzalutamide in Multiple Cancers",PR Newswire
Nov-07-18,Pfizer Rises 3%,Investing.com
Nov-07-18,"'We have a lot of things in common'  Trump wants to work with Democrats on infrastructure, drugs",CNBC
Nov-07-18,"Tariffs, Drug Prices, Legislative Gridlock: What Economists Are Watching Following The Midterm Election",Benzinga
Nov-07-18,NMC Healthcare Sukuk Limited -- Moody's assigns Ba1 rating to NMC's trust certificates,Moody's
Nov-08-18,ICU Medical Inc (ICUI) Q3 2018 Earnings Conference Call Transcript,Motley Fool
Nov-08-18,"Nektar (NKTR) Q3 Earnings & Sales Beat Estimates, Shares Up",Zacks
Nov-08-18,AstraZeneca sees years of growth as drug sales turn corner,Reuters
Nov-09-18,"Pharma Stock Roundup: LLY, AZN Report Q3 Earnings, PFE Gets FDA Nod for Cancer Drug",Zacks
Nov-12-18,Pfizer (PFE) Stock Moves -0.38%: What You Should Know,Zacks
Nov-12-18,These Biopharmas Could Cure Genetic Diseases  At $5 Million Apiece,Investor's Business Daily
Nov-13-18,"Walmart, Home Depot adopt health insurer tactic in drug copay battle",Reuters
Nov-14-18,Here's Why Sangamo Therapeutics Lost 12% Today,Motley Fool
Nov-14-18,"Pfizer loses drug patent fight in UK top court, may face claims",Reuters
Nov-14-18,7 Highest-Yielding Dow Dividend Stocks,Kiplinger
Nov-14-18,Pfizer loses blockbuster drug patent fight in UK Supreme Court,Reuters
Nov-14-18,Pfizer loses Lyrica drug patent fight in UK Supreme Court,Reuters
Nov-15-18,"Sangamo's Shares Drop on Rating Downgrade, Pipeline Woes",Zacks
Nov-15-18,Why Pfizer Is Up 19% in 2018 So Far,Motley Fool
Nov-15-18,3 Dividend Stocks Ideal for Retirees,Motley Fool
Nov-16-18,[$$] Pfizer to Raise Prices on 41 Drugs in January,The Wall Street Journal
Nov-16-18,[$$] Pfizer to Raise Prices on 41 Drugs,The Wall Street Journal
Nov-16-18,Pfizer to raise US drug prices in January after previously backing down,Reuters
Nov-16-18,Pfizer to raise drug prices in January,American City Business Journals
Nov-16-18,Pfizer to raise prices on 41 drugs: report,MarketWatch
Nov-16-18,Pfizer Plans Price Hikes for 41 Drugs Next Year,TheStreet.com
Nov-16-18,Pfizer to raise prices on 41 prescription drugs next year despite pressure from Trump,CNBC
Nov-16-18,"Final Trades: Virtu, JPMorgan & Pfizer",CNBC Videos
Nov-16-18,AstraZeneca Shows It Can Still Take Some Knocks,Bloomberg
Nov-16-18,[$$] Pfizer to raise prices for 41 drugs despite Trump criticism,Financial Times
Nov-19-18,Stock Market Today: Sea of Red,Investopedia
Nov-19-18,Pfizer (PFE) Gains As Market Dips: What You Should Know,Zacks
Nov-19-18,Pfizer Shares Jump on Monday After Company Signals Higher Price Push,TheStreet.com
Nov-19-18,Pfizer to raise drug prices despite Trumps complaints,Fox Business Videos
Nov-19-18,Tech Selloff Could Work in Favor of Pharmaceutical Stocks,TheStreet.com
Nov-19-18,Pfizer's Ovarian Cancer Treatment Fails In Late-Stage Test,Investor's Business Daily
Nov-19-18,"Pfizer Shares Rise Even as U.S. Lawmakers, Administration Criticize Drug Pricing",TheStreet.com
Nov-19-18,"Pfizer, Other Pharma Stocks Should Continue to Do Well Amid Market Volatility",TheStreet.com
Nov-19-18,Pfizer Lifting Prices on 41 Drugs in 2019,Investopedia
Nov-19-18,Pfizer's Oncology Offerings Present Opportunity for Long-Term Stock Growth,TheStreet.com
Nov-19-18,Jim Cramer Reacts to Pfizer's Drug Hikes,TheStreet.com
Nov-19-18,"Stocks - Apple Falls in Pre-market; Nissan, Renault, PG&E, JD.com Sink",Investing.com
Nov-19-18,Amgen's Blincyto Gets Positive CHMP Opinion for Line Extension,Zacks
Nov-19-18,"Drug Pricing Resurfaces, Pfizer to Raise Cost of 41 Drugs",Zacks
Nov-19-18,Pfizer Stock Slides Slightly as Drug-Maker Prepares Price Increases,TheStreet.com
Nov-19-18,Pfizer Could Rally in the Weeks Ahead as Investors Look Beyond Today's Headline,TheStreet.com
Nov-19-18,"The Zacks Analyst Blog Highlights: Pfizer, Cisco, Southern, SunTrust Banks and AmerisourceBergen",Zacks
Nov-19-18,Merck KGaA and Pfizer say drug failed to meet primary endpoints in late-stage ovarian cancer trial,MarketWatch
Nov-19-18,"Merck KGaA, Darmstadt, Germany, and Pfizer Provide Update on Avelumab in Platinum-Resistant/Refractory Ovarian Cancer",PR Newswire
Nov-19-18,Today's Research Reports on Trending Tickers: Facebook and Pfizer,ACCESSWIRE
Nov-19-18,"Carlos Ghosn, Apple, US-China Trade, Bitcoin and Pfizer - 5 Things You Must Know",TheStreet.com
Nov-20-18,Corcept Initiates Phase III Study for Cushing's Syndrome,Zacks
Nov-20-18,[$$] Diversis Capital Buys Controlling Stake of Tempo,The Wall Street Journal
Nov-20-18,Pfizer's Bavencio Phase III Study for Ovarian Cancer Fails,Zacks
Nov-20-18,Pfizer and 3 Other Stock Picks From a 5-Star Growth Fund,Barrons.com
Nov-20-18,[$$] Global markets retreat as tech rout spreads,Financial Times
Nov-21-18,FDA approves new blood cancer treatment from Pfizer,Reuters
Nov-21-18,Pfizer Stock Has Multiple Positive Catalysts,InvestorPlace
Nov-21-18,"Pfizer asks GOP Sen. Cindy Hyde-Smith for contribution refund, Facebook alum Sean Parker doesn't",CNBC
Nov-21-18,U.S. FDA Approves DAURISMO (glasdegib) for Adult Patients with Newly-Diagnosed Acute Myeloid Leukemia (AML) for Whom Intensive Chemotherapy is Not an Option,Business Wire
Nov-21-18,FDA approves Pfizer's treatment for rare blood cancer,Reuters
Nov-21-18,Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference,Business Wire
Nov-21-18,FDA Accepts Allergan's (AGN) sNDA for Anti-Infective Avycaz,Zacks
Nov-21-18,5 Quality Blue Chips to Thrive in Bull and Bear Markets,Investopedia
Nov-21-18,[$$] Global markets retreat as tech rout spreads,Financial Times
Nov-23-18,[$$] Pharma Stocks Soothe Stock-Market Malady,The Wall Street Journal
Nov-23-18,These 3 Stocks Are Up 25% in 2018 -- Are They Still Buys?,Motley Fool
Nov-23-18,"Pharma Stock Roundup: Cancer Approvals for PFE & ABBV, CHMP Nod for Several Drugs",Zacks
Nov-23-18,"Dow 30 Stock Roundup: Boeing to Supply 40 737 MAX 8 to Jeju Air, Pfizer Gets FDA Nod",Zacks
Nov-26-18,Google asks for refund of campaign contribution to embattled Sen. Cindy Hyde-Smith,CNBC
Nov-26-18,Spark Therapeutics' Luxturna Gets EU Approval for Vision Loss,Zacks
Nov-26-18,"Bayer looks at options for consumer brands, animal health - sources",Reuters
Nov-26-18,ATRS: Xyosted Launch Before Year End,Zacks Small Cap Research
Nov-26-18,"Bayer discusses sale of some consumer brands, future of animal health-sources",Reuters
Nov-26-18,"The Zacks Analyst Blog Highlights: Pfizer, AbbVie, J&J, Glaxo and AstraZeneca",Zacks
Nov-28-18,Merck raised prices five drugs including Keytruda in November,Reuters
Nov-28-18,Pfizer (PFE) Gains But Lags Market: What You Should Know,Zacks
Nov-28-18,Galapagos' Osteoarthritis Candidate Gets Fast Track Status,Zacks
Nov-28-18,Pfizer's Epilepsy Drug Lyrica Gets Pediatric Exclusivity,Zacks
Nov-28-18,Aileron Inks Collaboration Deal With Pfizer for Cancer Combo,Zacks
Nov-29-18,"Bayer To Cut 12,000 Jobs Amid Strategic Overhaul To Focus On Pharma",Investor's Business Daily
Nov-29-18,Why Pfizer Could Lead These Two Biotech Stocks In Tackling Amyloidosis,Investor's Business Daily
Nov-29-18,"Bayer to sell businesses, cut jobs after Monsanto deal",Reuters
Nov-29-18,Pfizer (PFE) Up 4.3% Since Last Earnings Report: Can It Continue?,Zacks
Nov-29-18,Roche (RHHBY) to Acquire Jecure and Enter the NASH Space,Zacks
Nov-29-18,4 Big Pharma Stocks to Add to Your Portfolio in December,Zacks
Nov-30-18,U.S. Stocks Sprint Ahead to End a Blockbuster Week,Barrons.com
Nov-30-18,Stock Market Stages Bullish Reversal To Cap Week With Big Gains,Investor's Business Daily
Nov-30-18,Pfizer Stock Edges Into Buy Zone On AbbVie Deal For Humira Biosimilar,Investor's Business Daily
Nov-30-18,Pfizer Is in Breakout-Mode This Fall: Chart,TheStreet.com
Nov-30-18,"Bulls shop for TJX. Plus, the trade on Pfizer",CNBC Videos
Nov-30-18,Pfizer Reaches a Global Agreement with AbbVie,Business Wire
Nov-30-18,"Dow 30 Stock Roundup: BA's $383M Modification Contract, MSFT's Army Contract",Zacks
Dec-03-18,"DARE: Ovaprene PCT Continues. TS Content Validity Study, Thermographic Study Underway",Zacks Small Cap Research
Dec-03-18,AbbVie Settles With Pfizer for Humira Biosimilar in U.S.,Zacks
Dec-03-18,"Mondays Vital Data: Pfizer, Goldman Sachs and Caterpillar",InvestorPlace
Dec-04-18,Pfizer (PFE) Stock Moves -1.78%: What You Should Know,Zacks
Dec-04-18,[$$] CEOs question the bite behind the bark of Trumps tweets,Financial Times
Dec-04-18,3 Big Pharma Stocks Hitting 52-Week Highs -- Are They Buys?,Motley Fool
Dec-06-18,Peninsula drug maker to pay $360M to settle Justice Department claims,American City Business Journals
Dec-06-18,Conatus' Emricasan Misses Primary Endpoint in Mid-Stage Study,Zacks
Dec-06-18,Pfizer Falls 3%,Investing.com
Dec-06-18,Exelixis Initiates Pivotal Liver Cancer Study on Cabometyx,Zacks
Dec-06-18,Four stocks have avoided the market crush to hit new highs,CNBC
Dec-06-18,China's Drugmakers Plunge Most Since 2009 on Price Concerns,Bloomberg
